Bradley S Quon

8PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapyInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLearning, motivation and emotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 09, 2025
Heterogeneity of short-term elexacaftor-tezacaftor-ivacaftor response in cystic fibrosis using 129Xe MRI.

Rachel L Eddy, Vanessa M Diamond, Josie Chrenek

|Apr 18, 2025
Early life inflammation in CF: can it be reversed by CFTR modulators?

Jasleen Kaur Matta, Bradley S Quon

|Nov 01, 2024
Reducing Treatment Burden in Cystic Fibrosis: Is There a Risk to OverSIMPLIFYing Therapies?

Bradley S Quon

|Aug 13, 2024
Blood Transcriptomic and Inflammatory Protein Biomarkers Associated with Imminent Pulmonary Exacerbation Risk in Cystic Fibrosis.

Kang Dong, Jiah Jang, Casey P Shannon

|Jun 04, 2020
Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis.

Bradley S Quon, Andrew H Ramsook, Satvir S Dhillon

|Oct 30, 2019
The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.

Valentine Sergeev, Frank Y Chou, Grace Y Lam

Pageof 2

Frequent Collaborators

1 joint publications

Anne L Stephenson

1 joint publications

Valentine Sergeev

1 joint publications

Kang Dong

1 joint publications

Rachel L Eddy